Industry News
Pharmaceutical Industry News
As Robert F. Kennedy Jr.’s…
As Robert F. Kennedy Jr.’s revamped CDC vaccine advisory panel gears up to meet next week, U.S. health officials are reportedly planning to connect the deaths of 25 children to the use of COVID shots.
Amid the Trump administration’s…
Amid the Trump administration’s call for a crackdown on direct-to-consumer pharmaceutical advertising, a new survey shows that many people with chronic conditions have been inspired by such ads to take some sort of action for
A federal judge granted Gilead…
A federal judge granted Gilead summary judgment in a lawsuit that claimed the company used sham speaker events to induce doctors to write hepatitis C drug prescriptions.
A week after rejecting an appeal…
A week after rejecting an appeal from BMS and J&J on the IRA price negotiation program, the same court has turned down a similar appeal from Novartis.
California Passes Bill Allowing Omission of Patients’ Names From Abortion Pill Bottles
The intent is to protect health care providers who send the pills to patients in states with abortion bans, and to reassure patients who fear they could be identified.
In the current climate, there is…
In the current climate, there is an urgent need for credible voices online, Doctor Mike noted in a discussion at Fierce Pharma Week. But the key is to create content that is transparent, authentic, educational
2025 Lasker Awards Given to Cell Biology and Cystic Fibrosis Pioneers
Many winners of the annual Lasker Awards have gone on to win a Nobel Prize in medicine or other fields.
The Jarring Contradiction at the Heart of RFK Jr.’s Agenda
The health secretary has begun a full-on assault against vaccines but has taken a more restrained approach to pesticides and unhealthy foods, also MAHA priorities.
In this episode of “The Top…
In this episode of “The Top Line,” Zoey Becker and Glenn Pierce, M.D., Ph.D., unpack why hemophilia gene therapies face barriers to adoption and which patients risk being left behind.
One day after announcing that it…
One day after announcing that it plans to cut 9,000 jobs in a major restructuring, Novo Nordisk has told its employees that office work will be mandatory at the start of next year.
With Rinvoq and its sibling…
With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the immunology
The FDA has officially put its…
The FDA has officially put its foot down on Intercept Pharmaceuticals’ rare liver disease drug Ocaliva, requesting that the company pull the med from the market and putting all of its related trials on a
Approved 15 months ago as a…
Approved 15 months ago as a pneumococcal disease vaccine for adults—and billed largely as the first shot designed for seniors—Merck’s Capvaxive has data supporting its potential in children and adolescents from a phase 3 trial.
Chicago-based investment firm GTCR…
Chicago-based investment firm GTCR has inked a deal to acquire Advent International's Prague-based generics manufacturer Zentiva. The transaction values Zentiva at 4.1 billion euros ($4.8 billion), The Financial Times reports.
Ongoing issues at Sun Pharma’s…
Ongoing issues at Sun Pharma’s production facility in Gujarat, India, have resulted in the FDA putting the facility on import alert status.
India’s Hikal Limited has been…
India’s Hikal Limited has been hit with a warning letter from the FDA that chided the API drugmaker for failing to uncover the cause of almost two dozen complaints of metal contamination in its products.
This year’s Fierce Pharma…
This year’s Fierce Pharma Marketing Awards gala, which took place in Philadelphia on Wednesday night, saw several major drugmakers take home trophies.
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
The highly debatable HARMONi data,…
The highly debatable HARMONi data, along with the trial design flaws and the unfortunate execution they reflect, plus a rapidly evolving competitive landscape, all point to one conclusion: Summit must partner with a Big Pharma
U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.